Clinical Trial Search Results

Clinical Trial Search Results

Showing 1-10 of 30

Sorted By:

  • AZA-MDS-006 (Connect)

    Connect® MDS and AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

  • CANOPY-A USOR 17167

    Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Completely Resected Non-small Cell Lung Cancer

  • CheckMate 9KD USOR 17149

    The purpose of this study is to assess the safety and efficacy of nivolumab in combination with rucaparib, docetaxel, or enzalutamide in participants with castration-resistant prostate cancer that has spread.

  • Genentech NSABP B-59

    A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo

  • Golden Biotech GHPanc-1-001

    A Phase I/II study to determine the maximum tolerated dose and to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of antroquinonol in combination with nab-paclitaxel and gemcitabine in first line metastatic pancreatic cancer.

  • MK-3475-158/KEYNOTE-158

    In this study, participants with multiple types of advanced solid tumors that have progressed on standard of care therapy will be treated with pembrolizumab.

  • MK-3475-756/KEYNOTE-756 USOR 17188

    Study of Pembrolizumab Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage ER+/HER2- Breast Cancer

  • MK-3475-775-KEYNOTE-775 USOR 17197

    Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer

  • MK-3475-KEYNOTE-564 USOR 16251

    Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy, RCC Clear Cell Component

  • MOST

    Study to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia or myelofibrosis.

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.